Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Current Deferred Revenue: 2021-2024

Historic Current Deferred Revenue for Core Scientific (CORZ) over the last 4 years, with Dec 2024 value amounting to $349,000.

  • Core Scientific's Current Deferred Revenue fell 85.17% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 85.17%. This contributed to the annual value of $349,000 for FY2024, which is 96.44% down from last year.
  • Per Core Scientific's latest filing, its Current Deferred Revenue stood at $349,000 for FY2024, which was down 96.44% from $9.8 million recorded in FY2023.
  • Core Scientific's 5-year Current Deferred Revenue high stood at $1.1 billion for FY2021, and its period low was $349,000 during FY2024.
  • In the last 3 years, Core Scientific's Current Deferred Revenue had a median value of $9.8 million in 2023 and averaged $29.3 million.
  • Data for Core Scientific's Current Deferred Revenue shows a maximum YoY slumped of 96.44% (in 2024) over the last 5 years.
  • Yearly analysis of 4 years shows Core Scientific's Current Deferred Revenue stood at $1.1 billion in 2021, then slumped by 92.60% to $77.7 million in 2022, then plummeted by 87.39% to $9.8 million in 2023, then plummeted by 96.44% to $349,000 in 2024.